Pharmacokinetics and Tissue Distribution of Idarubicin-Loaded Solid Lipid Nanoparticles After Duodenal Administration to Rats
- 1 May 2002
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 91 (5) , 1324-1333
- https://doi.org/10.1002/jps.10129
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats. Part I—A pharmacokinetic studyPharmacological Research, 2000
- Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to ratsPharmacological Research, 2000
- Biodistribution of Stealth and Non-stealth Solid Lipid Nanospheres after Intravenous Administration to RatsJournal of Pharmacy and Pharmacology, 2000
- Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Induction of apoptosis by idarubicin: how important is the plasma peak?Int. Journal of Clinical Pharmacology and Therapeutics, 2000
- Oral IdarubicinDrugs & Aging, 1997
- The Transfer of Polystyrene Microspheres from the Gastrointestinal Tract to the Circulation after Oral Administration in the RatJournal of Pharmacy and Pharmacology, 1995
- Clinical Pharmacokinetics of IdarubicinClinical Pharmacokinetics, 1993
- IdarubicinDrugs, 1991
- Analysis of 4-demethoxydaunorubicin and metabolites in plasma and urine.CHEMICAL & PHARMACEUTICAL BULLETIN, 1987